Sign In
Buy AMPE
$0.183
+0 (+0%)
At Close: Jun 03, 2026
Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC)
01:22am, Wednesday, 28'th Jan 2026
Institutional and Insider Ownership 44.0% of Vincerx Pharma shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 15.6% o
Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN)
02:00am, Thursday, 15'th Jan 2026
Profitability This table compares Trevena and Ampio Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Trevena N/A N/A -119.55% Ampio Ph
Ampio Pharmaceuticals (NYSE:AMPE) and Graybug Vision (NASDAQ:GRAY) Financial Contrast
01:58am, Sunday, 11'th Jan 2026
Volatility and Risk Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 5.57, indicating that it
Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
02:33pm, Wednesday, 03'rd Apr 2024
ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on Form
Ampio Announces Voluntary Delisting and SEC Deregistration
05:00pm, Monday, 25'th Mar 2024
ENGLEWOOD, Colo. , March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that its Board of Directors determined to voluntarily de
Ampio Provides Update on Results from Pre-IND Enabling Studies
05:45pm, Wednesday, 14'th Feb 2024
ENGLEWOOD, Colo. , Feb. 14, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), a pre-revenue stage biopharmaceutical company focused on development of a
Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions
04:15pm, Thursday, 11'th Jan 2024
ENGLEWOOD, Colo. , Jan. 11, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), a pre-revenue stage biopharmaceutical company focused on development of a
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
09:00am, Tuesday, 31'st Oct 2023
ENGLEWOOD, Colo. , Oct. 31, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential t
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
04:30pm, Thursday, 05'th Oct 2023
ENGLEWOOD, Colo. , Oct. 5, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company), a pre-revenue stage biopharmaceutical company focused on development of a potential tr
Ampio Pharmaceuticals to Present at the Emerging Growth Conference
09:15am, Tuesday, 26'th Sep 2023
ENGLEWOOD, Colo. , Sept. 26, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") a pre-revenue stage biopharmaceutical Company focused on development of a potential
Ampio Pharmaceuticals Announces Reverse Stock Split
06:30am, Thursday, 31'st Aug 2023
ENGLEWOOD, Colo. , Aug. 31, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Directors has approved a 20-to-1 reverse stock spli
3 Biotech Stocks to Buy With Explosive Upside Potential
09:30am, Thursday, 22'nd Jun 2023
The biotech sector will always house stocks with explosive upside potential. The very nature of the sector ensures that will continue to be the case.
NEW YORK, Oct. 7, 2022 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) between Decemb
Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket
10:19am, Wednesday, 14'th Sep 2022 Benzinga
Gainers
Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split.
Akerna Corp. (NASDAQ: KERN) shares rose 37.6% to $0.1789 in pre-market tra
Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket
11:27am, Thursday, 08'th Sep 2022 Benzinga
Gainers
Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.
AcelRx
